Skip to main content

Tissue Repair Health Care
Biotech Healthcare Pharmaceuticals

$0.270 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
17 September 2026 at 4:07pm
Register to track TRP and receive email alerts.
TRP Announcements on Price Chart

Latest Announcements

Headline Date
Change of Company Secretary 28 June 2023 at 7:05pm
Change of Director's Interest Notice - JL 6 June 2023 at 6:45pm
FDA clears TR-987 to progress to Phase 3 29 May 2023 at 9:55am
Notification of cessation of securities - TRP 17 May 2023 at 10:35am
Final Director's Interest Notice - MJ 2 May 2023 at 4:55pm
Final Director's Interest Notice - CS 2 May 2023 at 4:50pm
Initial Director's Interest Notice - MS 2 May 2023 at 4:50pm
Quarterly Activities/Appendix 4C Cash Flow Report 28 April 2023 at 5:00pm
Changes to Board of Directors 26 April 2023 at 6:59pm
Bank Deposits At SVB Available Tuesday 14 March 2023 AEDT 13 March 2023 at 1:40pm
Update on Cash Held with Silicon Valley Bank 13 March 2023 at 10:20am
Appendix 4D and Half Year Report to 31 December 2022 22 February 2023 at 5:30pm
Quarterly Activities/Appendix 4C Cash Flow Report 30 January 2023 at 12:50pm
Constitution 24 November 2022 at 11:50am
Results of Meeting 23 November 2022 at 1:40pm
AGM Presentation 23 November 2022 at 10:30am
Company Presentation 8 November 2022 at 10:25am
Bell Potter Healthcare Conference Invitation 7 November 2022 at 7:30pm
Quarterly Activities/Appendix 4C Cash Flow Report 28 October 2022 at 9:35am
Notice of Annual General Meeting/Proxy Form 21 October 2022 at 11:40am
TR Pro accepted for peer reviewed journal publication 12 October 2022 at 7:20pm
Change of Company Secretary 28 September 2022 at 12:10pm
FDA Response Clarifies Path to Phase 3 Trials 28 September 2022 at 11:59am
Second US Patent granted for Glucoprime 5 September 2022 at 10:30am
Appendix 4G and Corporate Governance Statement 31 August 2022 at 4:10pm
Appendix 4E and Annual Report 30 June 2022 31 August 2022 at 4:10pm
Quarterly Activities/Appendix 4C Cash Flow Report 29 July 2022 at 8:40am
Lodgement of Type C Meeting Request with US FDA 1 July 2022 at 10:20am
Notice under ASX Listing Rule 3.10A 11 May 2022 at 5:25pm
Application for quotation of securities - TRP 3 May 2022 at 12:20pm
Quarterly Activities/Appendix 4C Cash Flow Report 29 April 2022 at 4:45pm
Notice under ASX Listing Rule 3.10A 22 April 2022 at 9:15am
Change of Director's Interest Notice 29 March 2022 at 4:25pm
Tissue Repair Announces USA Patent Approval 4 March 2022 at 10:45am
Appendix 4D and Half Year Report to 31 December 2021 25 February 2022 at 9:50am
Quarterly Activities/Appendix 4C Cash Flow Report 31 January 2022 at 12:20pm
Correction to Appendix 3Y 8 December 2021 at 7:10pm
Tissue Repair Progresses TR-987 towards Phase III 23 November 2021 at 10:05am
Change of Director's Interest Notice - Tony Charara 23 November 2021 at 10:00am
Change of Director's Interest Notice - Jack Lowenstein 23 November 2021 at 10:00am
Change of Director's Interest Notice - Max Johnston 23 November 2021 at 10:00am
Becoming a substantial holder 22 November 2021 at 7:40pm
Becoming a substantial holder 22 November 2021 at 7:40pm
Initial Director's Interest Notice - Tony Charara 22 November 2021 at 7:25pm
Initial Director's Interest Notice - Bryan Gray 22 November 2021 at 7:20pm
Initial Director's Interest Notice - Max Johnston 22 November 2021 at 7:20pm
Initial Director's Interest Notice - Jack Lowenstein 22 November 2021 at 7:20pm
Initial Director's Interest Notice - Craig Stamp 22 November 2021 at 7:20pm
Becoming a substantial holder 22 November 2021 at 5:05pm
Becoming a substantial holder 22 November 2021 at 5:05pm
Register to track TRP and receive email alerts.